Hirofumi Kai News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hirofumi kai. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hirofumi Kai Today - Breaking & Trending Today

Anti-diabetic drug metformin inhibits disease progression in Alport syndrome mouse model


Anti-diabetic drug metformin inhibits disease progression in Alport syndrome mouse model
Researchers from Kumamoto University (Japan) have found that the anti-diabetic drug metformin significantly prolongs the survival of mice in a model that simulates the pathology of non-diabetic chronic kidney disease (ND-CKD) by ameliorating pathological conditions like reduced kidney function, glomerular damage, inflammation and fibrosis. Metformin s mechanism is different from existing therapeutics which only treat symptoms, such as the blood pressure drug losartan, so the researchers believe that a combination of these medications at low dose will be highly beneficial.
CKD (chronic kidney disease) is a general term for kidney damage that results from persistent decline in kidney function due to proteinuria, kidney inflammation, or fibrosis. As CKD progresses, patients are forced to undergo dialysis, and diabetes is one of its biggest risk factors. CKD can also occur in association w ....

Hirofumi Kai , Emily Henderson , Kumamoto University Japan , Research Project Leader , Kumamoto University , Research Project , ஹிரோபூமி கை , எமிலி ஹென்டர்சன் , குமாமோடோ பல்கலைக்கழகம் ஜப்பான் , குமாமோடோ பல்கலைக்கழகம் , ஆராய்ச்சி ப்ராஜெக்ட் ,

New benefits from anti-diabetic drug metformin | EurekAlert! Science News


 E-Mail
Credit: Professor Hirofumi Kai
Researchers from Kumamoto University (Japan) have found that the anti-diabetic drug metformin significantly prolongs the survival of mice in a model that simulates the pathology of non-diabetic chronic kidney disease (ND-CKD) by ameliorating pathological conditions like reduced kidney function, glomerular damage, inflammation and fibrosis. Metformin s mechanism is different from existing therapeutics which only treat symptoms, such as the blood pressure drug losartan, so the researchers believe that a combination of these medications at low dose will be highly beneficial.
CKD (chronic kidney disease) is a general term for kidney damage that results from persistent decline in kidney function due to proteinuria, kidney inflammation, or fibrosis. As CKD progresses, patients are forced to undergo dialysis, and diabetes is one of its biggest risk factors. CKD can also occur in association with lifestyle-related conditions such as hype ....

Hirofumi Kai , Kumamoto University Japan , Kumamoto University , Professor Hirofumi Kai , Medicine Health , Internal Medicine , Urogenital System , Pharmaceutical Chemistry , ஹிரோபூமி கை , குமாமோடோ பல்கலைக்கழகம் ஜப்பான் , குமாமோடோ பல்கலைக்கழகம் , ப்ரொஃபெஸர் ஹிரோபூமி கை , உயிர் வேதியியல் ,